Ever Source Wealth Advisors, LLC Nanobiotix S.A. Transaction History
Ever Source Wealth Advisors, LLC
- $2.2 Billion
- Q3 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 514 shares of NBTX stock, worth $10,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
514
Previous 517
0.58%
Holding current value
$10,506
Previous $2,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NBTX
# of Institutions
12Shares Held
5.88MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$115 Million26.6% of portfolio
-
Black Rock Inc. New York, NY239KShares$4.89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.2KShares$208,1600.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P75.36KShares$109,4760.0% of portfolio
-
Morgan Stanley New York, NY2.38KShares$48,6060.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $713M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...